Sensitizing Staphylococcus aureus to antibacterial agents by decoding and blocking the lipid flippase MprF

Abstract

The pandemic of antibiotic resistance represents a major human health threat demanding new antimicrobial strategies. MprF is the synthase and flippase of the phospholipid lysyl-phosphatidylglycerol that increases virulence and resistance of methicillin-resistant Staphylococcus aureus (MRSA) and other pathogens to cationic host defense peptides and antibiotics. With the aim to design MprF inhibitors that could sensitize MRSA to antimicrobial agents and support the clearance of staphylococcal infections with minimal selection pressure, we developed MprF-targeting monoclonal antibodies, which bound and blocked the MprF flippase subunit. Antibody M-C7.1 targeted a specific loop in the flippase domain that proved to be exposed at both sides of the bacterial membrane, thereby enhancing the mechanistic understanding of bacterial lipid translocation. M-C7.1 rendered MRSA susceptible to host antimicrobial peptides and antibiotics such as daptomycin, and it impaired MRSA survival in human phagocytes. Thus, MprF inhibitors are recommended for new anti-virulence approaches against MRSA and other bacterial pathogens.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Christoph Josef Slavetinsky

    Pediatric Gastroenterology and Hepatology, Eberhard Karls University Tübingen, Tübingen, Germany
    For correspondence
    christoph.slavetinsky@med.uni-tuebingen.de
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5576-5906
  2. Janna Nadine Hauser

    Department of Infection Biology, Eberhard Karls University Tübingen, Tübingen, Germany
    Competing interests
    No competing interests declared.
  3. Cordula Gekeler

    Department of Infection Biology, Eberhard Karls University Tübingen, Tübingen, Germany
    Competing interests
    No competing interests declared.
  4. Jessica Slavetinsky

    Department of Infection Biology, Eberhard Karls University Tübingen, Tübingen, Germany
    Competing interests
    No competing interests declared.
  5. André Geyer

    Department of Infection Biology, Eberhard Karls University Tübingen, Tübingen, Germany
    Competing interests
    No competing interests declared.
  6. Alexandra Kraus

    MorphoSys AG, Planegg, Germany
    Competing interests
    Alexandra Kraus, Antibodies disclosed in the manuscript are part of patent Anti-staphylococcal antibodies" (US9873733B2 / EP2935324B1).
  7. Doris Heilingbrunner

    MorphoSys AG, Planegg, Germany
    Competing interests
    No competing interests declared.
  8. Samuel Wagner

    Cluster of Excellence 'Controlling Microbes to Fight Infections', University of Tübingen, Tübingen, Germany
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1808-3556
  9. Michael Tesar

    MorphoSys AG, Planegg, Germany
    Competing interests
    Michael Tesar, Antibodies disclosed in the manuscript are part of patent Anti-staphylococcal antibodies" (US9873733B2 / EP2935324B1).
  10. Bernhard Krismer

    Department of Infection Biology, Eberhard Karls University Tübingen, Tübingen, Germany
    Competing interests
    No competing interests declared.
  11. Sebastian Kuhn

    Department of Infection Biology, Eberhard Karls University Tübingen, Tübingen, Germany
    Competing interests
    No competing interests declared.
  12. Christoph M Ernst

    Department of Molecular Biology and Center for Computational and Integrative Biology, Broad Institute, Cambridge, United States
    For correspondence
    cmernst@broadinstitute.org
    Competing interests
    Christoph M Ernst, Antibodies disclosed in the manuscript are part of patent Anti-staphylococcal antibodies" (US9873733B2 / EP2935324B1).
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5575-1325
  13. Andreas Peschel

    Department of Infection Biology, Eberhard Karls University Tübingen, Tuebingen, Germany
    Competing interests
    Andreas Peschel, Antibodies disclosed in the manuscript are part of patent Anti-staphylococcal antibodies" (US9873733B2 / EP2935324B1).

Funding

Deutsche Forschungsgemeinschaft (EXC-2124/1-09.001_0)

  • Christoph Josef Slavetinsky

Deutsche Forschungsgemeinschaft (EXC-2124/1-09.010_0)

  • Christoph Josef Slavetinsky

Deutsches Zentrum für Infektionsforschung (TTU 08.806)

  • Christoph Josef Slavetinsky

Deutsches Zentrum für Infektionsforschung (TTU 08.806)

  • Andreas Peschel

Deutsche Forschungsgemeinschaft (SFB 766/1-3,TP A08)

  • Andreas Peschel

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2022, Slavetinsky et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,417
    views
  • 418
    downloads
  • 28
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Christoph Josef Slavetinsky
  2. Janna Nadine Hauser
  3. Cordula Gekeler
  4. Jessica Slavetinsky
  5. André Geyer
  6. Alexandra Kraus
  7. Doris Heilingbrunner
  8. Samuel Wagner
  9. Michael Tesar
  10. Bernhard Krismer
  11. Sebastian Kuhn
  12. Christoph M Ernst
  13. Andreas Peschel
(2022)
Sensitizing Staphylococcus aureus to antibacterial agents by decoding and blocking the lipid flippase MprF
eLife 11:e66376.
https://doi.org/10.7554/eLife.66376

Share this article

https://doi.org/10.7554/eLife.66376

Further reading

    1. Microbiology and Infectious Disease
    Mehak Zahoor Khan, Debbie M Hunt ... Vinay Kumar Nandicoori
    Research Article

    Mycobacterium tuberculosis’s (Mtb) autarkic lifestyle within the host involves rewiring its transcriptional networks to combat host-induced stresses. With the help of RNA sequencing performed under various stress conditions, we identified that genes belonging to Mtb sulfur metabolism pathways are significantly upregulated during oxidative stress. Using an integrated approach of microbial genetics, transcriptomics, metabolomics, animal experiments, chemical inhibition, and rescue studies, we investigated the biological role of non-canonical L-cysteine synthases, CysM and CysK2. While transcriptome signatures of RvΔcysM and RvΔcysK2 appear similar under regular growth conditions, we observed unique transcriptional signatures when subjected to oxidative stress. We followed pool size and labelling (34S) of key downstream metabolites, viz. mycothiol and ergothioneine, to monitor L-cysteine biosynthesis and utilization. This revealed the significant role of distinct L-cysteine biosynthetic routes on redox stress and homeostasis. CysM and CysK2 independently facilitate Mtb survival by alleviating host-induced redox stress, suggesting they are not fully redundant during infection. With the help of genetic mutants and chemical inhibitors, we show that CysM and CysK2 serve as unique, attractive targets for adjunct therapy to combat mycobacterial infection.

    1. Microbiology and Infectious Disease
    2. Physics of Living Systems
    Tingting Yang, Marko S Chavez ... Mohamed Y El-Naggar
    Research Article

    Filamentous multicellular cable bacteria perform centimeter-scale electron transport in a process that couples oxidation of an electron donor (sulfide) in deeper sediment to the reduction of an electron acceptor (oxygen or nitrate) near the surface. While this electric metabolism is prevalent in both marine and freshwater sediments, detailed electronic measurements of the conductivity previously focused on the marine cable bacteria (Candidatus Electrothrix), rather than freshwater cable bacteria, which form a separate genus (Candidatus Electronema) and contribute essential geochemical roles in freshwater sediments. Here, we characterize the electron transport characteristics of Ca. Electronema cable bacteria from Southern California freshwater sediments. Current–voltage measurements of intact cable filaments bridging interdigitated electrodes confirmed their persistent conductivity under a controlled atmosphere and the variable sensitivity of this conduction to air exposure. Electrostatic and conductive atomic force microscopies mapped out the characteristics of the cell envelope’s nanofiber network, implicating it as the conductive pathway in a manner consistent with previous findings in marine cable bacteria. Four-probe measurements of microelectrodes addressing intact cables demonstrated nanoampere currents up to 200 μm lengths at modest driving voltages, allowing us to quantify the nanofiber conductivity at 0.1 S/cm for freshwater cable bacteria filaments under our measurement conditions. Such a high conductivity can support the remarkable sulfide-to-oxygen electrical currents mediated by cable bacteria in sediments. These measurements expand the knowledgebase of long-distance electron transport to the freshwater niche while shedding light on the underlying conductive network of cable bacteria.